1285 - Systematic Literature Review of Real-world Experience with the 2-Drug Regimen Dolutegravir and Lamivudine in People with HIV Who Would Not Have Met Inclusion Criteria for the Phase 3 Clinical Program

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Jihad Slim, MD, FACP

Medical Director
Saint Michael’s Medical Center, Newark, NJ, USA
Newark, New Jersey, United States

DW

Douglas Ward, MD

Physician
Dupont Circle Physicians Group, Washington, DC, USA
Washington, District of Columbia, United States
SS

Stefan Schneider, MD

Long Beach Education and Research Consultants, Long Beach, CA, USA
Long Beach, California, United States
MK

Madhusudan Kabra, BPharm, MSc

ViiV Healthcare, Brentford, UK
Brentford, England, United Kingdom
GV

Gustavo Verdier, BSc, BPharm, MBA

ViiV Healthcare, Montréal, QC, Canada
Pointe-Claire, Quebec, Canada
CJ

Clifford B. Jones, BSc MSc MB ChB

Global medical lead
ViiV Healthcare, Brentford, UK
London, England, United Kingdom
Emilio Letang, MD, MPH, PhD

Global Scientific Advisor
ViiV Healthcare, Madrid, Spain
Madrid, Madrid, Spain